|
Index of reports
> Cases resulting in hospitalization (9)
> Cases with Breast Cancer (6)
Below is the selection of adverse event reports related to Estratest (Esterified Estrogens) that includes cases resulting in hospitalization where reactions include breast cancer.
Adverse event in 55 year old female receiving Estratest (Esterified Estrogens)
Reported by a physician from United States on 2007-07-11
Patient: 55 year old female, weighing 62.1 kg (136.6 pounds)
Adverse reactions / side effects: Breast Cancer
Adverse event resulted in: hospitalization
Suspect drug(s):
Activella
Indication: Hormone Replacement Therapy
Start date: 2001-06-01
End date: 2002-06-01
Prempro
Dosage: 0.625 mg / 2.5 mg
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2001-06-01
Estratest
Indication: Hormone Replacement Therapy
Start date: 1999-11-01
End date: 2002-06-01
Other drugs received by patient: Medroxyprogesterone Acetate; Provera; Estrace; Estring; Serzone; Effexor XR; Xanax
Adverse event in 66 year old female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-07-10
Patient: 66 year old female, weighing 56.7 kg (124.7 pounds)
Adverse reactions / side effects: Pyrexia, Macrognathia, Vaginal Disorder, Smear Cervix Abnormal, Mammogram Abnormal, Colonic Polyp, Coeliac Disease, Irritable Bowel Syndrome, Bone Density Decreased, Temperature Intolerance, Cough, Breast Cancer, Pneumonia, Vaginal Discharge, Breast Mass, Cataract Operation, Meniere's Disease, Temporomandibular Joint Syndrome, Vision Blurred, Platelet Count Decreased, Gastric Polyps, Lactose Intolerance, Restless Legs Syndrome, Thrombocythaemia, Blood Thyroid Stimulating Hormone Increased, Hepatitis, Hypokalaemia, Pleural Effusion, Genital Disorder Female, Blood Cholesterol Increased, Depression, Injury, Gastrooesophageal Reflux Disease, Loss of Libido, Cataract, Breast Disorder, Hepatic Enzyme Increased, Anxiety, Mucosal Inflammation, Oral Pain, Epigastric Discomfort, Mastectomy, Hypothyroidism, Hypertension
Adverse event resulted in: hospitalization
Suspect drug(s):
Combipatch
Indication: Menopause
Start date: 1991-01-01
Combipatch
Dosage: 0.25 mg, unk
Start date: 2000-01-01
End date: 2000-01-01
Provera
Dosage: 5 mg for 14 days every other month
Indication: Menopause
Start date: 1995-08-01
End date: 1995-09-01
Estraderm
Dosage: 0.05 mg, unk
Indication: Menopause
Start date: 1994-12-01
End date: 2002-01-01
Vivelle
Dosage: 0.05 mg, unk
Indication: Menopause
Aygestin
Ogen
Indication: Menopause
Estratest
Premarin
Prempro
Estrogenic Substance
Oragest
Indication: Menopause
Premarin
Indication: Menopause
Start date: 1990-01-01
End date: 1992-01-01
Premarin
Start date: 1990-01-01
End date: 1992-01-01
Premarin
Start date: 1990-01-01
End date: 1992-01-01
Adverse event in 62 year old female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-07-02
Patient: 62 year old female, weighing 99.8 kg (219.5 pounds)
Adverse reactions / side effects: Polyp Colorectal, Mammogram Abnormal, Fibrocystic Breast Disease, Intervertebral Disc Disorder, Postmenopausal Haemorrhage, Breast Microcalcification, Blood Cholesterol Increased, Benign Breast Neoplasm, Breast Hyperplasia, Breast Cancer, Tonsillectomy, Abscess Drainage, Mastitis, Radiotherapy, Malignant Breast Lump Removal, Appendicitis, Anal Fissure, Haematochezia, Hysterectomy, Uterine Dilation and Curettage, Colonoscopy Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Estraderm
Start date: 1989-01-01
Premarin
Dosage: 0.625 unk, unk
Administration route: Oral
Start date: 1989-01-01
Prempro
Indication: Menopause
Start date: 1999-04-01
End date: 2002-04-01
Provera
Dosage: 10 mg, unk
Start date: 1989-01-01
Estratest
Start date: 1990-01-01
End date: 1999-01-01
Cycrin
Start date: 1999-01-01
Estrace
Dosage: unk, qhs
Start date: 1999-01-01
Other drugs received by patient: Steroids NOS; Oxygen Therapy; Lotrel; Cardizem
Adverse event in 59 year old female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-04-20
Patient: 59 year old female, weighing 59.0 kg (129.7 pounds)
Adverse reactions / side effects: Abdominal Pain, Pain, Rectal Haemorrhage, Endometrial Hypertrophy, Colonic Polyp, Breast Cyst, Fibrocystic Breast Disease, Haemangioma of Liver, Depression Suicidal, Neck Pain, Uterine Leiomyoma, Breast Microcalcification, Breast Cosmetic Surgery, Postmenopausal Haemorrhage, Injury, Exostosis, Radiculopathy, Intervertebral Disc Protrusion, Breast Cancer, Dyspareunia, Spinal Cord Compression, Haemorrhoids, Breast Mass, Radiotherapy, Modified Radical Mastectomy, Suicide Attempt, Spinal Osteoarthritis
Adverse event resulted in: hospitalization
Suspect drug(s):
Estraderm
Dosage: 0.05 mg twice weekly
Indication: Hormone Replacement Therapy
Start date: 1993-08-20
End date: 1997-03-04
MPA
Dosage: unk, qd one tab
Administration route: Oral
Indication: Menopause
Start date: 1993-08-09
End date: 1997-05-01
Provera
Dosage: unk, qd, one tab
Administration route: Oral
Indication: Menopause
Start date: 1993-08-09
End date: 1997-05-01
Premarin
Dosage: 0.625 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1993-08-09
End date: 1993-08-20
Premphase 14 / 14
Dosage: .625/5 mg/day
Administration route: Oral
Indication: Menopause
Start date: 1996-04-12
End date: 1999-03-10
Estratest
Dosage: unk, qhs tab
Administration route: Oral
Indication: Menopause
Start date: 1997-04-16
End date: 1997-05-01
Prempro
Dosage: 0.625 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1999-03-10
End date: 1999-07-09
Premarin
Dosage: 0.6 unk, unk
Administration route: Topical
Indication: Vulvovaginal Dryness
Start date: 2000-04-07
End date: 2003-03-04
Other drugs received by patient: Prozac; Valium; Evista; Contraceptives NOS
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-04-06
Patient: female, weighing 51.2 kg (112.7 pounds)
Adverse reactions / side effects: Breast Cancer
Adverse event resulted in: hospitalization
Suspect drug(s):
Vagifem
Dosage: unk, unk
Indication: Menopausal Symptoms
Start date: 2002-01-07
End date: 2003-11-21
Estrogen NOS
Dosage: unknown
Indication: Menopausal Symptoms
Cenestin
Dosage: .625 mg, unk
Indication: Menopausal Symptoms
Start date: 2002-08-09
End date: 2003-08-01
Prometrium
Dosage: 100 mg, unk
Indication: Menopausal Symptoms
Start date: 2002-06-20
End date: 2004-04-15
Estring
Dosage: unknown
Indication: Menopausal Symptoms
Start date: 2001-07-09
End date: 2002-01-01
Menest
Dosage: .3 mg, unk
Indication: Menopausal Symptoms
Start date: 2003-06-18
End date: 2004-01-02
Femring
Dosage: unk, unk
Indication: Menopausal Symptoms
Start date: 2003-12-15
Estratest
Dosage: .625 mg, unk
Indication: Menopausal Symptoms
Start date: 2002-06-20
End date: 2002-08-09
Other drugs received by patient: Prosom; Ultram; Wellbutrin
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a lawyer from United States on 2007-03-20
Patient: female
Adverse reactions / side effects: Breast Cancer, Diabetes Mellitus, Pancreatitis, Cerebrovascular Accident
Adverse event resulted in: hospitalization
Suspect drug(s):
Prempro
0.1mg Levonorgestrel / 0.02mg Ethinyl Estradiol / Inert
Medroxyprogesterone Acetate
Depo-Provera
Estratest
Medroxyprogesterone Acetate
Indication: Hormone Replacement Therapy
Premarin
Other drugs received by patient: Glucophage; Lopid; Pravachol; Ativan; Ascorbic Acid; Vitamin B Complex CAP; Synthroid
|
